Source Date | Board Meeting Date | Details |
22-May-2025
|
27-May-2025
|
Audited Results
|
08-Apr-2025
|
14-Apr-2025
|
Inter alia; consider and approve the following agenda: 1. Pursuant to the approved resolution plan sanctioned by the Hon'ble National Company Law Tribunal, Chandigarh bench, we propose to explore funding opportunities through the issuance of Compulsory Convertible Debentures (CCDs) in one or more tranches, as permitted under applicable laws and subject to the terms of the approved resolution plan
|
06-Feb-2025
|
11-Feb-2025
|
Quarterly Results
|
30-Jan-2025
|
04-Feb-2025
|
Inter alia, to consider and approve:- 1. To approve the restructuring of the share capital and shareholding of the Company pursuant to the order of Hon ble National Company Law Tribunal (NCLT), chandigarhbench under the provisions of the provisions of 30(6) read with 31(1) of the IBC, 2016 and Sec 60(5) of the IBC, 2016, read with R.11 (NCLT Rules, 2016). 2. To approve the allotment of 19673500 Equity Share to new promoter and public pursuant to the order dated 01.07.2024 of Hon ble National Company Law Tribunal, Chandigarh Bench (NCLT) under the provisions of 30(6) read with 31(1) of the Insolvency and Bankruptcy Code, 2016 (IBC, 2016) and Sec 60(5) of the IBC, 2016, read with Rule 11 (National Company Law Tribunal Rules, 2016).
|
03-Dec-2024
|
06-Dec-2024
|
Audited Results Inter alia, to consider and approve:- 1. To explore opportunities of fund raising through Issuance of Compulsory Convertible Debenture (CCDs), in one or more tranches, subject to the necessary approvals and in accordance with the provision of Companies Act, 2013 and SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 as amended from time to time; 2. To consider and approve the Audited Financial Results along with the Audit Report for the Financial Year ended on 31st March, 2024; 3. To consider and appoint M/s Krishan Rakesh & Co., Chartered Accountants (Firm Registration No.: 009088N, Peer Review Certificate No.: 016602), as Statutory Auditor of the Company for a term of 5 (five) consecutive years from financials year 2024-2025 till the conclusion of the 38th Annual General Meeting to be held in the year 2029. 4. Any other matter with the permission of the Chairman of the meeting.
|
06-Feb-2023
|
14-Feb-2023
|
Quarterly Results
|
23-May-2022
|
30-May-2022
|
Audited Results
|
08-Nov-2021
|
09-Nov-2021
|
Quarterly Results (Revised)
|
01-Nov-2021
|
08-Nov-2021
|
Quarterly Results
|
06-Aug-2021
|
13-Aug-2021
|
Quarterly Results
|